These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11348485)

  • 1. Pharmacokinetic profile and in vitro selective cyclooxygenase-2 inhibition by nimesulide in the dog.
    Toutain PL; Cester CC; Haak T; Metge S
    J Vet Pharmacol Ther; 2001 Feb; 24(1):35-42. PubMed ID: 11348485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential inhibition by nimesulide of the early and late phases of intravenous- and intracerebroventricular-LPS-induced fever in guinea pigs.
    Steiner AA; Li S; Llanos-Q J; Blatteis CM
    Neuroimmunomodulation; 2001; 9(5):263-75. PubMed ID: 11964521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview.
    Famaey JP
    Inflamm Res; 1997 Nov; 46(11):437-46. PubMed ID: 9427063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: a comparative study.
    King JN; Rudaz C; Borer L; Jung M; Seewald W; Lees P
    Res Vet Sci; 2010 Jun; 88(3):497-506. PubMed ID: 20004922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor.
    Davies NM; McLachlan AJ; Day RO; Williams KM
    Clin Pharmacokinet; 2000 Mar; 38(3):225-42. PubMed ID: 10749518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmacokinetic/pharmacodynamic approach vs. a dose titration for the determination of a dosage regimen: the case of nimesulide, a Cox-2 selective nonsteroidal anti-inflammatory drug in the dog.
    Toutain PL; Cester CC; Haak T; Laroute V
    J Vet Pharmacol Ther; 2001 Feb; 24(1):43-55. PubMed ID: 11348486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral and intravenous administration of nimesulide in the horse: rational dosage regimen from pharmacokinetic and pharmacodynamic data.
    Villa R; Cagnardi P; Belloli C; Zonca A; Zizzadoro C; Ferro E; Carli S
    Equine Vet J; 2007 Mar; 39(2):136-42. PubMed ID: 17378442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and bioavailability of nimesulide in goats.
    Rao GS; Malik JK; Siddaraju VB; Shankaramurthy NC
    J Vet Pharmacol Ther; 2007 Apr; 30(2):157-62. PubMed ID: 17348902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beings.
    Panara MR; Padovano R; Sciulli MG; Santini G; Renda G; Rotondo MT; Pace A; Patrono C; Patrignani P
    Clin Pharmacol Ther; 1998 Jun; 63(6):672-81. PubMed ID: 9663182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral bioavailability and pharmacokinetics of DRF-4367, a new COX-2 inhibitor in rats.
    Ramesh M; Mamidi RN; Jagannath K; Singh SK; Rao KS; Rao YK; Seshagirirao C; Rajagopalan R; Srinivas NR
    Eur J Drug Metab Pharmacokinet; 2003; 28(2):137-41. PubMed ID: 12877572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in cats with lipopolysaccharide-induced pyrexia.
    McCann ME; Rickes EL; Hora DF; Cunningham PK; Zhang D; Brideau C; Black WC; Hickey GJ
    Am J Vet Res; 2005 Jul; 66(7):1278-84. PubMed ID: 16111170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vivo assessment of nimesulide cyclooxygenase-2 selectivity.
    Shah AA; Murray FE; Fitzgerald DJ
    Rheumatology (Oxford); 1999 May; 38 Suppl 1():19-23. PubMed ID: 10369402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.
    Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y
    Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating among nonsteroidal antiinflammatory drugs by pharmacokinetic and pharmacodynamic profiles.
    Fenner H
    Semin Arthritis Rheum; 1997 Jun; 26(6 Suppl 1):28-33. PubMed ID: 9219317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective cyclooxygenase-2 inhibition by nimesulide in man.
    Cullen L; Kelly L; Connor SO; Fitzgerald DJ
    J Pharmacol Exp Ther; 1998 Nov; 287(2):578-82. PubMed ID: 9808683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental models used to investigate the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2 by non-steroidal anti-inflammatory drugs.
    Pairet M; van Ryn J
    Inflamm Res; 1998 Oct; 47 Suppl 2():S93-101. PubMed ID: 9831330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibition of cyclooxygenase isoenzymes in the cat by the NSAID robenacoxib.
    Giraudel JM; Toutain PL; King JN; Lees P
    J Vet Pharmacol Ther; 2009 Feb; 32(1):31-40. PubMed ID: 19161453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of nimesulide.
    Bennett A
    Rheumatology (Oxford); 1999 May; 38 Suppl 1():1-3. PubMed ID: 10369398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.